
* Laboratory of Experimental Immunology, Division of Basic Sciences, and
Intramural Research Support Program, SAIC Frederick, National Cancer Institute-FCRDC, Frederick, Maryland
Correspondence: Stephen K. Anderson, SAIC-Frederick, NCI-FCRDC, Bldg. 560, Rm. 31-93, Frederick, MD 21702-1201. E-mail: andersn{at}mail.ncifcrf.gov
Previous studies have indicated that NK cells from different strains of inbred mice may express distinct Ly49 repertoires. Screening of NK cells from the CBA/J mouse for inhibitory and activating Ly49s revealed a novel DAP12-associated receptor that was immunoprecipitated with the Ly49G-specific mAb 4D11. Degenerate primers were designed to amplify and clone Ly49 cDNAs from CBA/J NK cells. A novel activating Ly49 cDNA was identified, which bears strong homology to the partially sequenced Ly49l gene found in C57BL/6 mice. Transfection of Ly49l into a DAP12+ cell line and subsequent immunoprecipitation experiments showed that Ly49L is likely the activating Ly49 detected by the 4D11 antibody in CBA/J NK cells. Antibody-mediated cross-linking of Ly49L induced DAP12 phosphorylation, providing evidence that Ly49L is a functional activating receptor. Comparison of the extracellular domains of Ly49 family members indicates that all known activating members have an inhibitory counterpart with a highly related extracellular region.
Key Words: NK cells Ly49 cell surface receptors signal transduction
This article has been cited by other articles:
![]() |
O. Zohar, Y. Reiter, J. R. Bennink, A. Lev, S. Cavallaro, S. Paratore, C. G. Pick, G. Brooker, and J. W. Yewdell Cutting Edge: MHC Class I-Ly49 Interaction Regulates Neuronal Function J. Immunol., May 15, 2008; 180(10): 6447 - 6451. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kielczewska, H.-S. Kim, L. L. Lanier, N. Dimasi, and S. M. Vidal Critical Residues at the Ly49 Natural Killer Receptor's Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like Protein J. Immunol., January 1, 2007; 178(1): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shimizu, J. Koike, H. Wakao, K.-i. Seino, H. Koseki, T. Kakiuchi, T. Nakayama, and M. Taniguchi Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: analysis with KLRE-1-deficient mice Blood, August 1, 2004; 104(3): 781 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Mason, J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I J. Immunol., October 15, 2003; 171(8): 4235 - 4242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raziuddin, D. L. Longo, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, and W. J. Murphy Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens Blood, September 26, 2002; 100(8): 3026 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saleh, A. P. Makrigiannis, D. L. Hodge, and S. K. Anderson Identification of a Novel Ly49 Promoter That Is Active in Bone Marrow and Fetal Thymus J. Immunol., May 15, 2002; 168(10): 5163 - 5169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Makrigiannis, A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson Class I MHC-Binding Characteristics of the 129/J Ly49 Repertoire J. Immunol., April 15, 2001; 166(8): 5034 - 5043. [Abstract] [Full Text] [PDF] |
||||